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Abstract  
Introduction: Haemodialysis is one of the widely used methods in end stage renal disease. However it has a negative impact on the quality of life 
of the renal patients. Hypoalbuminaemia occur in haemodialysis patients and it correlates strongly with mortality and morbidity. We sought out to 
determine the prevalence of hypoalbuminaemia among haemodialysis patients at Parirenyatwa group of hospitals and Chitungwiza central hospital. 
Methods: A questionnaire was administered on haemodialysis patients at Parirenyatwa Group of Hospitals and Chitungwiza Central Hospital who 
consented to participate in the study. Pre dialysis serum samples collected from the patients were used for albumin analysis. The serum from the 
patients was analysed for serum albumin levels using the Mindray BS120 chemistry analyser using the bromocresol green method. Results: A total 
of 60 patients were recruited from the two hospitals. The Mean albumin concentration for the entire group was 33.6g/L SD (6.1 g/L). The mean 
albumin in males was 33.6 g/L, SD (5.9) and in female 33.6, SD (6.6 g/L) and this was not statistically significantly different (p=0.988). The 
prevalence of hypoalbuminaemia was 76.7%. Conclusion: Hypoalbuminaemia in 76.7% of haemodialysis patients studied is a cause of concern 
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Introduction 
 
End stage renal disease is an important public health problem. 
Renal replacement therapy, dialysis and transplantation are used to 
provide relief from the symptoms of end stage renal disease whilst 
also preserving the life of the patients though they are not curative. 
Haemodialysis is the widely used method although it produces a 
negative impact on quality of life of the patients [1]. 
Hypoalbumianemia has been reported to be frequently present in 
haemodialysis patients and correlates strongly with mortality and 
morbidity. Levels of albumin are decreased in patients with 
inflammatory states, thus it's not clear to what extent 
hypoalbuminemia is due to malnutrition or simply a reflection of 
inflammatory states [2]. Patients with advanced chronic kidney 
disease who receive chronic hemodialysis treatment suffer from 
various degrees of protein energy wasting. Low serum albumin is 
one of the key diagnostic criteria proposed by the International 
Society of Renal Nutrition Experts Panel [3]. Serum albumin is still 
the most common nutritional marker used in end stage renal 
disease patients [4]. Serum albumin measurement is a simple and 
readily available test [5]. We sought out to determine the 
prevalence of hypoalbuminaemia among haemodialysis patients at 





Data and sample collection 
  
Permission to carry out the project was sought from the authorities 
at Parirenyatwa Group of Hospitals, Chitungwiza Central Hospital 
and Joint Research Ethics Committee of the College of Health 
Sciences. Only patients who consented were recruited into the study 
between January and February 2013. A questionnaire was 
administered on haemodialysis patients at Parirenyatwa Group of 
Hospitals and Chitungwiza Central Hospital who consented to 
participate in the study. The questionnaire was used to collect 
demographic information and other information from the patient. 
Serum from the pre dialysis blood samples collected from the 







The serum from the patients was analysed for serum albumin levels 
using the Mindray BS120 chemistry analyser using the bromocresol 
green method. The analyser was calibrated and control samples 
were analysed before analysis of samples. Samples were only 
analysed when the control samples were within their reference 





The data was captured using Microsoft excel and exported to Stata 
12 for cleaning and analysis. Patients characteristics were 
summarized using mean (SD) for continuous normally distributed 
variables. Categorical variables were summarized using frequencies 
and percentages. Hypoalbuminaemia was defined as serum albumin 





A total of 60 patients were enrolled into the study with a mean age 
of 46.7 years, SD (13.5 years). The majority of the patients 70% 
(42/60) were male. There was no significant difference in age 
distribution between males (mean age=48.5 years, SD=12.8 years) 
and females (mean age=42.7 years, SD=14.6 years), (p=0.134). 
Mean albumin concentration for the entire group was 33.6g/L SD 
(6.1 g/L). The mean albumin in males was 33.6 g/L, SD (5.9) and in 
female 33.6, SD (6.6 g/L) and this was not statistically significantly 
different (p=0.988). Prevalence of hypoalbuminaemia was 76.7% 
(Table 1). Being female had a protective effect against 
hypoalbuminaemia compared to being male but this was not 
statistically significant, OR=0.71, 95% CI (0.20-2.52), p=0.595. The 
odds of developing hypoalbuminaemia increased with age but was 
not statistically significant, OR=1.02, 95% CI (0.98-1.07), p=0.318. 
Period on dialysis was not a significant predictor of 
hypoalbuminaemia OR=0.99, 95% CI (0.98-1.01). Having BP was 
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Discussion 
 
It has been reported that morbidity and mortality incidence of 
dialysed patients with hypoalbuminemia is higher than in patients 
with normal serum albumin [7]. Mean albumin concentration for the 
entire group was 33.6 g/L SD (6.1 g/L). The mean albumin in males 
was 33.6 g/L, SD (5.9) and in female 33.6, SD (6.6 g/L) and this 
was not statistically significantly different (p=0.988). This is a cause 
of concern since patients with a serum albumin levels below 35g/L 
have been reported to have a relative mortality risk of 4 or a 2 year 
survival of 20% when compared with a 2 year survival of 80% in 
those with serum albumin greater than 40g/L [8]. The mean 
albumin of the entire group was less than 40.7g/L reported in 300 
end stage renal disease patients in Tehran University of Medical 
Sciences Hospital during the year 2010 [4]. 
  
In dialysis patients low serum albumin level indicates more severe 
comorbidity, worse general health status and protein energy 
wasting [3]. The prevalence of hypoalbuminemia in this study was 
found to be 76.7% which is lower than that reported in Pakistan of 
90.6% [9]. The study in Parkistan used a cut of for 
hypoalbuminaemia of 40g/L which is more than the 38g/L which is 
currently recommended. In dialysis patients the amino acid and 
protein losses during the dialysis session and the low nutrient intake 
leads to low nutrient availability for muscle synthesis [10]. Oral 
nutritional supplements and other nutritional interventions to 
chronic kidney disease patients have been suggested to increase 
serum albumin levels and improve longevity and their quality of life 
[5]. Several studies have reported that haemodialysis patients eat 
less protein and fewer calories than prescribed and are associated 





Hypoalbuminaemia in 76.7% of haemodialysis patients studied is a 
cause of concern thus monitoring of haemodialysis patients albumin 
is necessary since its decreased levels has been associated with 
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Table 1: Prevalence of hypoalbuminaemia 
Albumin category Frequency Percent Frequency 
Normal 14 23.3 
hypoalbuminaemia 46 76.7 
